Actively Recruiting
The ASSESS National Multi-center Prospective Cohort
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2020-03-13
395
Participants Needed
1
Research Sites
730 weeks
Total Duration
On this page
Sponsors
A
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
S
Societe Francaise de Rhumatologie
Collaborating Sponsor
AI-Summary
What this Trial Is About
The ASSESS national multi-center prospective cohort (Assessment of Systemic complications (Signs) and Evolution in Sjögren's Syndrome "SS") was set up in 2006 thanks to a grant of the French Ministry of Health. Fifteen centers for autoimmune diseases consecutively included consecutive patients with Primary Sjögren's Syndrome "pSS" fulfilling American-European Consensus Criteria (AECG) between 2006 and 2009. The study was approved by the Ethics Committee of Bichat Hospital in 2006. All patients gave their informed written consent. This study was followed for 5 years with the grant of the French Ministry of Health and this study will be extended for 20 years by French Society of Rheumatology (SFR). On an annual basis for a duration of 20 years, a thorough standardized paper case report form (CRF) was filled prospectively by clinicians.
CONDITIONS
Official Title
The ASSESS National Multi-center Prospective Cohort
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older
- Primary Sj�f6gren's Syndrome patients who have already participated in the ASSESS study
You will not qualify if you...
- Secondary Sj�f6gren's Syndrome associated with other autoimmune diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hopital Bicêtre
Le Kremlin-Bicêtre, Val De Marne, France, 94270
Actively Recruiting
Research Team
X
Xavier Mariette
CONTACT
J
Jacques-Eric Gottenberg
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here